TABLE 3.
Antimicrobial susceptibility and genotypic and epidemiologic characteristics of the 37 aac(3)-IIg-positive E. cloacae complex isolates
| Straina | Resistance profileb | Aminoglycoside resistance genesc | Pulsotype |
|---|---|---|---|
| Y3 | GEN, KAN, STR, TOB, NEO, NET | aac(3)-IIg, strA, strB, aphA-1 | 3 |
| Y4 | GEN, KAN, STR, NEO | aac(3)-IIg , strA , strB , aac(6')-IIc , aphA-1 | 18 |
| Y7 | GEN, KAN, STR, TOB, NEO, NET | aac(3)-IIg, strA, strB, aac(6')-IIc, aphA-1 | 3 |
| Y8 | GEN, KAN, STR, TOB, NEO, NET | aac(3)-IIg , strA , strB , aac(6')-IIc , aphA-1 | 9 |
| Y10 | GEN, KAN, STR, TOB, NET | aac(3)-IIg , strA , strB , aac(6')-IIc | 13 |
| Y24 | GEN, KAN, STR, TOB, NEO, NET | aac(3)-IIg , strA , strB , aac(6')-IIc , aphA-1 | 18 |
| Y40 | GEN, KAN, STR, TOB, NEO, NET | aac(3)-IIg , strA , strB , aac(6')-IIc , aphA-1 | 23 |
| Y43 | GEN, KAN, STR, TOB, NEO, NET | aac(3)-IIg , strA , strB , aac(6')-IIc , aphA-1 | 23 |
| Y59 | GEN, KAN, STR, TOB, NEO, NET | aac(3)-IIg , strA , strB , aac(6')-IIc , aphA-1 | 23 |
| Y67 | GEN, KAN, STR, TOB, NEO, NET | aac(3)-IIg , strA , strB , aac(6')-IIc , aphA-1 | 21 |
| Y75 | GEN, KAN, STR, TOB, NEO, NET | aac(3)-IIg , strA , strB , aac(6')-IIc , aphA-1 | 7 |
| Y81 | GEN, KAN, STR, TOB, NEO, NET | aac(3)-IIg , strA , strB , aphA-1 | 17 |
| Y88 | GEN, KAN, STR, TOB, NET | aac(3)-IIg , strA , strB , aac(6')-IIc | 16 |
| Y108 | GEN, KAN, STR, TOB, NET | aac(3)-IIg , strA , strB , aac(6')-IIc | 4 |
| Y118 | GEN, KAN, STR, TOB, NEO, NET | aac(3)-IIg , strA , strB , aac(6')-IIc | 21 |
| Y129 | GEN, KAN, STR, TOB, NEO, NET | aac(3)-IIg , strA , strB , aac(6')-IIc , aphA-1 | 5 |
| Y130 | GEN, KAN, STR, TOB, NEO, NET | aac(3)-IIg , strA , strB | 5 |
| Y131 | GEN, KAN, STR, TOB, NEO, NET | aac(3)-IIg , strA , strB , aphA-1 | 5 |
| Y137 | GEN, KAN, STR, TOB, NEO, NET | aac(3)-IIg, strA, strB, aac(6')-IIc, aphA-1 | 15 |
| Y150 | GEN, KAN, STR, TOB, NEO, NET | aac(3)-IIg, strA, strB, aac(6')-IIc, aphA-1 | 22 |
| Y165 | GEN, KAN, STR, TOB, NEO, NET | aac(3)-IIg , strA , strB , aac(6')-IIc , aphA-1 | 2 |
| Y176 | GEN, KAN, STR, TOB, NEO, NET | aac(3)-IIg, strA, strB, aac(6')-IIc, aphA-1 | 11 |
| Y178 | GEN, KAN, STR, TOB, NEO, NET | aac(3)-IIg, strA, strB, aac(6')-IIc, aphA-1 | 22 |
| Y184 | GEN, KAN, STR, TOB, NEO, NET | aac(3)-IIg, strA, strB, aac(6')-IIc, aphA-1 | 19 |
| Y233 | GEN, KAN, STR, TOB, NEO, NET, SPE, AMK | aac(3)-IIg , strA , strB , aac(6')-IIc , aadA1 , aphA-1 , armA | 1 |
| Y243 | GEN, KAN, STR, TOB, NEO, NET | aac(3)-IIg , strA , strB , aac(6')-IIc , aphA-1 | 22 |
| Y249 | GEN, KAN, STR, TOB, NET | aac(3)-IIg , strA , strB , aac(6')-IIc | 6 |
| Y261 | GEN, KAN, STR, TOB, NEO, NET | aac(3)-IIg , strA , strB , aac(6')-IIc , aphA-1 | 9 |
| Y274 | GEN, KAN, STR, TOB, NEO, NET, SPE, AMK | aac(3)-IIg, strA, strB, aac(6')-IIc, aadA1, aphA-1, armA | 1 |
| Y295 | GEN, KAN, STR, TOB, NEO, NET | aac(3)-IIg, strA, strB, aac(6')-IIc, aphA-1 | 10 |
| Y308 | GEN, KAN, STR, TOB, NET | aac(3)-IIg, strA, strB, aac(6')-IIc | 20 |
| Y315 | GEN, KAN, STR, TOB, NEO, NET | aac(3)-IIg , strA , strB , aac(6')-IIc , aphA-1 | 8 |
| Y320 | GEN, KAN, STR, NEO | aac(3)-IIg, strA, strB, aac(6')-IIc, aphA-1, aac(3)-IId | 10 |
| Y323 | GEN, KAN, STR, TOB, NEO, NET, SPE | aac(3)-IIg, strA, strB, aac(6')-IIc, aphA-1, aac(3)-IId, aadA2 | 14 |
| Y324 | GEN, KAN, STR, TOB, NET | aac(3)-IIg , strA , strB , aac(6')-IIc | 12 |
| Y327 | GEN, KAN, STR, TOB, NET | aac(3)-IIg , strA , strB , aac(6')-IIc | 19 |
| Y2152 | GEN, KAN, STR, NEO | aac(3)-IIg, strA, strB, aac(6')-IIc, aphA-1 | 10 |
a
Isolates with transconjugants are underlined.
b
The resistance phenotypes transferred to the recipient by conjugation are underlined. Abbreviations: GEN, gentamicin; KAN, kanamycin; STR, streptomycin; TOB, tobramycin; SPE, spectinomycin; AMK, amikacin; NEO, neomycin; NET, netilmicin.
c
Genes that were cotransferred by conjugation are underlined.